Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chevret

Showing results (221-230 of 226) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 226 results.
Neurology|August 6, 2008
Dehydroepiandrosterone for myotonic dystrophy type 1I Pénisson-Besnier, M Devillers, R Porcher, et al.
Blood|August 10, 1999
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL GroupP Fenaux, C Chastang, S Chevret, et al.
Blood|May 9, 2001
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemiaV Rocha, J Cornish, E L Sievers, et al.
British Journal of Haematology|December 21, 2000
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trialS De Botton, S Chevret, M Sanz, et al.
Bone Marrow Transplantation|June 27, 2017
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and EurocordS Nguyen, A Achour, L Souchet, et al.
Leukemia|October 27, 2015
Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletionA Toma, O Kosmider, S Chevret, et al.
Pageof 23

Showing results (221-230 of 226) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 226 results.
Neurology|August 6, 2008
Dehydroepiandrosterone for myotonic dystrophy type 1I Pénisson-Besnier, M Devillers, R Porcher, et al.
Blood|August 10, 1999
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL GroupP Fenaux, C Chastang, S Chevret, et al.
Blood|May 9, 2001
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemiaV Rocha, J Cornish, E L Sievers, et al.
British Journal of Haematology|December 21, 2000
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trialS De Botton, S Chevret, M Sanz, et al.
Bone Marrow Transplantation|June 27, 2017
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and EurocordS Nguyen, A Achour, L Souchet, et al.
Leukemia|October 27, 2015
Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletionA Toma, O Kosmider, S Chevret, et al.
Pageof 23